Article
Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells
2023-01-30
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Despite recent advances in locoregional, systemic, and novel checkpoint inhibitor treatment, hepatocellular carcinoma (HCC) is still associated with poor prognosis. The feasibility of potentially curative liver resection (LR) and transplantation (LT) is limited by underlying liver disease and a shortage of organ donors. Especially after LR, we are dealing with h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5636eebf-fab9-58ad-acf5-e56415324700
- DOI
- 10.21203/rs.3.rs-2495698/v1
